NCT03982524

Brief Summary

The purpose of this study is to evaluate whether 3 years after the end of therapy cognitive-behavioral therapy complemented with strategies from emotion regulation training leads to better improvement in somatic symptoms and comorbid problems in patients with chronic multiple somatoform symptoms than cognitive behavioral therapy alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
255

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2017

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

June 8, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 11, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2019

Completed
Last Updated

July 14, 2025

Status Verified

July 1, 2025

Enrollment Period

2.5 years

First QC Date

June 8, 2019

Last Update Submit

July 9, 2025

Conditions

Keywords

somatoform symptomssomatic symptomssomatoform disordersomatic symptom disordercognitive-behavioral therapyemotion regulation training3-year follow-up

Outcome Measures

Primary Outcomes (1)

  • Change in somatic symptom severity (Screening of Somatoform Disorders, SOMS-7T) from pre-assessment to 3-year follow-up

    Assessment of somatic symptom severity during the last 7 days (self-rating)

    From pre-assessment (admission) to follow-up (42 months after admission)

Secondary Outcomes (7)

  • Change in depressive symptoms (Beck Depression Inventory-II, BDI-II) from pre-assessment to 3-year follow-up

    From pre-assessment (admission) to follow-up (42 months after admission)

  • Change in emotion regulation skills (Emotion Regulation Skills Questionnaire, ERSQ) from pre-assessment to 3-year follow-up

    From pre-assessment (admission) to follow-up (42 months after admission)

  • Change in symptom-focused coping strategies (Pain Coping Questionnaire) from pre-assessment to 3-year follow-up

    From pre-assessment (admission) to follow-up (42 months after admission)

  • Change in general psychopathological symptoms (Symptom Checklist-90, SCL-90) from pre-assessment to 3-year follow-up

    From pre-assessment (admission) to follow-up (42 months after admission)

  • Change in symptom-caused disability (Pain Disability Index, PDI) from pre-assessment to 3-year follow-up

    From pre-assessment (admission) to follow-up (42 months after admission)

  • +2 more secondary outcomes

Study Arms (2)

CBT complemented with emotion regulation training

EXPERIMENTAL

ENCERT contains 1) psychoeducation (session1), 2) relaxation techniques for coping with stress (sessions 2-4), 3) non-judgmental awareness of body perceptions, (sessions 5-7), 4) modifying illness behavior and accepting unpleasant body perceptions (sessions 8-13), 5) attention defocusing on positive perceptions plus emotional self-support (sessions 14- 15), 6) analyzing interpretation processes to understand situational cues (sessions 16-17), and 7) change of behavior and interpretations (sessions 18-20). The innovative elements of ENCERT are: improving the awareness for the association of somatic symptoms with emotions, learning nonjudgmental awareness and acceptance of unpleasant body perceptions, achieving high-frequent skill exercising with the emotion regulation audio training.

Behavioral: Cognitive-behavioral therapy + emotion regulation training for patients with multiple somatoform symptoms

Cognitive behavior therapy (CBT)

ACTIVE COMPARATOR

This arm is based on conventional cognitive-behavioral therapy that can be considered the current "treatment of choice", being the only intervention with an evidence grade 1a (Kroenke, 2007). As such, it presents the reference of efficacy and safety for new regimen. The strictly manualized program includes the following components focusing on the special needs of chronic somatoform patients: psychoeducation providing a framework for psychotherapy, attention defocusing, reduction of over-interpretation of symptoms, increase of physical activity, stress reduction.

Behavioral: Cognitive-behavioral therapy for patients with multiple somatoform symptoms

Interventions

Cognitive-behavioral therapy + emotion regulation training for patients with multiple somatoform symptoms: 20 weekly sessions individual therapy (à 50 minutes)

CBT complemented with emotion regulation training

Cognitive-behavioral therapy for patients with multiple somatoform symptoms: 20 weekly sessions individual therapy (à 50 minutes)

Cognitive behavior therapy (CBT)

Eligibility Criteria

Age18 Years - 69 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Multiple distressing somatic symptoms (≥ 3 symptoms) not fully explained by a medical condition
  • Pain Disability Index (mPDI) total score ≥ 4
  • Patient Health Questionnaire-15 (PHQ-15) ≥ 5
  • Requested psychological criteria for SSD (at least 1 of 3):
  • Disproportionate and persistent thoughts about the seriousness of one's symptoms
  • Persistently high level of anxiety about health or symptoms
  • Excessive time and energy devoted to these symptoms or health concerns
  • Symptom duration ≥ 6 months
  • Age: 18-69 years
  • Comorbidity (depression, other mental disorders) allowed, as long as somatic symptoms are considered to be the major problem by therapist and patient
  • Thorough medical check for medical disease that might fully explain the somatic symptoms
  • Documented medical evaluation

You may not qualify if:

  • Severe alcohol/drug addiction
  • Acquired brain injuries
  • Psychoses (history of schizophrenia spectrum disorders; bipolar disorders)
  • Primary disorder requesting other treatments (e.g., suicidality)
  • Biomedical etiology of major symptoms (also if detected during treatment course
  • Ongoing psychotherapy
  • Continuous or intermittent, high-dosage (on average more than once per 2 weeks) benzodiazepine treatment
  • Continuous antipsychotic treatment
  • Continuous opioid treatment
  • For patients on medication with antidepressants: treatment regime changes during the time between 4 weeks prior to treatment until follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Psychology, Philipps University Marburg

Marburg, Hesse, 35032, Germany

Location

MeSH Terms

Conditions

Medically Unexplained SymptomsSomatoform Disorders

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Maria Kleinstäuber, PhD

    Philipps University Marburg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 8, 2019

First Posted

June 11, 2019

Study Start

April 1, 2017

Primary Completion

September 30, 2019

Study Completion

September 30, 2019

Last Updated

July 14, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

Data sharing statement Will individual participant data be available (including data dictionaries)? Yes What data in particular will be shared? Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices). What other documents will be available? Study protocol With whom? Researchers who provide a methodologically sound proposal for re-analyses For what types of analyses? For re-analyses if their aim is covered by the purpose described and agreed on in the patient information sheet and informed consent.

Shared Documents
STUDY PROTOCOL
Time Frame
Immediately following publication; no end date
Access Criteria
Proposals should be directed to the corresponding author (MK; maria.kleinstaeuber@staff.uni-marburg.de). To gain access, data requestors will need to sign a data access agreement. Data are not publicly available because informed consent provided by participants of this study is committed to a defined purpose.

Locations